Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-032642
Filing Date
2025-04-16
Accepted
2025-04-16 17:15:52
Documents
6
Period of Report
2025-04-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0238464-6k_akanda.htm 6-K 11764
2 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF THE SHAREHOLDERS OF AKANDA CORP. ea023846401ex99-1_akanda.htm EX-99.1 89719
3 PROXY CARD ea023846401ex99-2_akanda.htm EX-99.2 1626
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5269
5 GRAPHIC ex99-2_001.jpg GRAPHIC 1469103
6 GRAPHIC ex99-2_002.jpg GRAPHIC 1534544
  Complete submission text file 0001213900-25-032642.txt   4247281
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 25843576
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)